Zu "K04277" wurden 386 Artikel gefunden!
Für die Filterung wurden keine Ergebnisse gefunden!
NEU
ADB-5'F-BUTINACA
Artikelnummer: Cay37761-1
ADB-5'F-BUTINACA (Cay-37761) is an analytical reference standard categorized as a synthetic cannabinoid. This product is intended for research and forensic applications.Formal Name: (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-5-fluoro-1H-indazole-3-carboxamide. Molecular Formula: C18H25FN4O2. Formula...
| Schlagworte: | ADB-B-5'F-INACA, ADB-BUT-5'F-INACA, (S)-N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-5-fluoro-1H-indazole-3-carboxamide |
| Anwendung: | Analytical reference standard, synthetic cannabinoid |
| MW: | 348.4 D |
ab 111,00 €
JWH 116
Artikelnummer: Cay13977-1
JWH 116 (Cay-13977) is a synthetic cannabinoid (CB) receptor ligand from the naphthoylindole family. It is the indole 2-ethyl derivative of the related compound JWH 018 (Cay-10900 and 13169) and has a Ki value of 52 nM for the CB1 receptor. This product is intended for research and forensic applications.Formal Name:...
| Schlagworte: | (2-ethyl-1-pentyl-1H-indol-3-yl)-1-naphthalenyl-methanone |
| Anwendung: | Analytical reference standard, synthetic cannabinoid, CB1 receptor agonist |
| CAS | 619294-64-3 |
| MW: | 369.5 D |
ab 60,00 €
CB1 antagonist 2
Artikelnummer: TGM-T14881-100mg
Description: CB1 antagonist 2 (AM4113) is caimabinoid 1 (CB1) antagonist which inhibits CB1 in vivo with an IC50 of 25.5 nM. Target: Cannabinoid Receptor. Smiles: Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(N)=O. References: Song Li, et al. 4-methyl-diaryl -1H- pyrazole derivatives and their use as medicamentsFIELD.
| Schlagworte: | AM4113 |
| Anwendung: | CNR1-selective neutral antagonist |
| CAS | 614726-85-1 |
| MW: | 380.66 D |
ab 31,00 €
Rimonabant hydrochloride
Artikelnummer: TGM-T1519-100mg
Description: Rimonabant hydrochloride (SR 141716A) is a cannabinoid receptor antagonist, binding selectively to central cannabinoid receptors (CB1) with high affinity. Target: Antibacterial, Cannabinoid Receptor. Smiles: n1(nc(c(c1c1ccc(cc1)Cl)C)C(=O)NN1CCCCC1)c1c(cc(cc1)Cl)Cl.Cl. References: Vivian JA, et al....
| Schlagworte: | SR 151716A, SR 141716A |
| Anwendung: | CB1 inverse agonist |
| CAS | 158681-13-1 |
| MW: | 500.25 D |
ab 38,00 €
Rimonabant
Artikelnummer: TGM-T1519L-100mg
Description: Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the...
| Schlagworte: | SR141716 |
| Anwendung: | Targets cannabinoid receptor 1 (CNR1) |
| CAS | 168273-06-1 |
| MW: | 463.79 D |
ab 42,00 €
LH 21
Artikelnummer: TGM-T21811-1mg
Description: LH-21 is a potent in vivo neutral cannabinoid CB1 receptor antagonist that reduces food intake and body weight gain in obese Zucker rats, resulting in a dose-dependent inhibition of feeding [1]. Target: Others. Smiles: ClC1=C(N2C(=NC(CCCCCC)=N2)C3=CC=C(Cl)C=C3)C=CC(Cl)=C1
| Anwendung: | CB1 antagonist |
| CAS | 611207-11-5 |
| MW: | 408.75 D |
ab 147,00 €
GAT211
Artikelnummer: TGM-T27405-100mg
Description: GAT211 (AZ-4) is a selective and potent cannabinoid 1 receptor (CB1R) orthosteric modulator (PAM) with high affinity for cAMP and beta-arrestin2.GAT211 has IOP-lowering and antipsychotic effects and can be used in the study of epilepsy. Target: Cannabinoid Receptor, cAMP, Arrestin. Smiles:...
| Schlagworte: | AZ 4, GAT-211, AZ4, AZ-4, GAT 211 |
| Anwendung: | Cannabinoid receptor 1 agonist / positive allosteric modulator (PAM) |
| CAS | 102704-40-5 |
| MW: | 342.39 D |
ab 31,00 €
Levonantradol hydrochloride
Artikelnummer: TGM-T27819-25mg
Description: Levonantradol hydrochloride is a new compound with antiemetic activity. Target: Others. Smiles: O(C(C)=O)C1=C2[C@]3([C@]([C@H](C)NC2=CC(O[C@@H](CCCC4=CC=CC=C4)C)=C1)(CC[C@@H](O)C3)[H])[H].Cl. References: McIlhenny HM, Mast RW, Johnson MR, Milne GM. Nantradol hydrochloride: pharmacokinetics and...
| Schlagworte: | CP-50,556-1, Levonantradol HCl, CP 50,556-1 |
| Anwendung: | Targets cannabinoid receptor 1 (CNR1) |
| CAS | 70222-86-5 |
| MW: | 474.03 D |
1.943,00 €
PSNCBAM-1
Artikelnummer: TGM-T28468-100mg
Description: PSNCBAM-1 (PSNCBAM 1) is a CB1 receptor negative allosteric modulator (EC50 = 0.1 µM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies. Target: Cannabinoid Receptor. Smiles: N(C(NC1=CC=C(Cl)C=C1)=O)C=2C=C(C=3N=C(C=CC3)N4CCCC4)C=CC2. References: Wang X, et al. Effects of the...
| Schlagworte: | PSNCBAM 1 |
| Anwendung: | Cannabinoid (CB) receptor 1 antagonist |
| CAS | 877202-74-9 |
| MW: | 392.88 D |
ab 48,00 €
MDMB-CHMINACA
Artikelnummer: TGM-T28006-10mg
Description: MDMB-CHMINACA, an indazole-based synthetic cannabinoid, acts as a potent agonist of the CB1 receptor. Target: Others. Smiles: C(N1C=2C(C(C(N[C@H](C(OC)=O)C(C)(C)C)=O)=N1)=CC=CC2)C3CCCCC3. References: Banister, Samuel D., Longworth, Mitchell, Kevin, Richard, Sachdev, Shivani, Santiago, Marina, Stuart,...
| Schlagworte: | (S)-MDMB-CHMINACA |
| Anwendung: | Indazole-based synthetic cannabinoid (AB-CHMINACA related) |
| CAS | 1185888-32-7 |
| MW: | 385.5 D |
ab 193,00 €
Otenabant
Artikelnummer: TGM-T3530-100mg
Description: Otenabant (CP-945598) has been investigated for the treatment of Obesity. Target: Cannabinoid Receptor. Smiles: CCNC1(CCN(CC1)c1ncnc2n(c(nc12)-c1ccccc1Cl)-c1ccc(Cl)cc1)C(N)=O. References: John R. Hadcock, et al. In vitro and in vivo pharmacology of CP-945,598, a potent and selective cannabinoid CB1...
| Schlagworte: | CP-945598 |
| Anwendung: | Targets cannabinoid receptor 1 (CNR1) |
| CAS | 686344-29-6 |
| MW: | 510.42 D |
ab 41,00 €
CHM-081
Artikelnummer: TGM-T30903-10mg
Description: JWH 081, a cannabimimetic aminoalkylindole, has a high-affinity to the central cannabinoid (CB1) receptor (Ki =1.2 nM) and ten-fold reduced affinity to the peripheral cannabinoid (CB2) receptor (Ki = 12.4 nM). JWH 081-N-(cyclohexylmethyl) analog is a synthetic CB where a cyclohexylmethyl group replaces...
| Schlagworte: | CHM 081 |
| Anwendung: | Synthetic cannabinoid analog |
| CAS | 1373876-34-6 |
| MW: | 397.51 D |
ab 193,00 €